Cargando…
Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292589/ https://www.ncbi.nlm.nih.gov/pubmed/33939192 http://dx.doi.org/10.1111/bcp.14843 |
| _version_ | 1784749408796016640 |
|---|---|
| author | den Heijer, Jonas M. Heuberger, Jules A. A. C. Hijma, Hemme Kruithof, Annelieke C. van Smeden, Jeroen Groeneveld, Geert Jan Burggraaf, Jacobus Cohen, Adam |
| author_facet | den Heijer, Jonas M. Heuberger, Jules A. A. C. Hijma, Hemme Kruithof, Annelieke C. van Smeden, Jeroen Groeneveld, Geert Jan Burggraaf, Jacobus Cohen, Adam |
| author_sort | den Heijer, Jonas M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9292589 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92925892022-07-20 Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines den Heijer, Jonas M. Heuberger, Jules A. A. C. Hijma, Hemme Kruithof, Annelieke C. van Smeden, Jeroen Groeneveld, Geert Jan Burggraaf, Jacobus Cohen, Adam Br J Clin Pharmacol Commentary John Wiley and Sons Inc. 2021-05-03 2021-12 /pmc/articles/PMC9292589/ /pubmed/33939192 http://dx.doi.org/10.1111/bcp.14843 Text en © 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Commentary den Heijer, Jonas M. Heuberger, Jules A. A. C. Hijma, Hemme Kruithof, Annelieke C. van Smeden, Jeroen Groeneveld, Geert Jan Burggraaf, Jacobus Cohen, Adam Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines |
| title | Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines |
| title_full | Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines |
| title_fullStr | Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines |
| title_full_unstemmed | Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines |
| title_short | Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines |
| title_sort | good clinical trials by removing defensive interpretation of good clinical practice guidelines |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292589/ https://www.ncbi.nlm.nih.gov/pubmed/33939192 http://dx.doi.org/10.1111/bcp.14843 |
| work_keys_str_mv | AT denheijerjonasm goodclinicaltrialsbyremovingdefensiveinterpretationofgoodclinicalpracticeguidelines AT heubergerjulesaac goodclinicaltrialsbyremovingdefensiveinterpretationofgoodclinicalpracticeguidelines AT hijmahemme goodclinicaltrialsbyremovingdefensiveinterpretationofgoodclinicalpracticeguidelines AT kruithofanneliekec goodclinicaltrialsbyremovingdefensiveinterpretationofgoodclinicalpracticeguidelines AT vansmedenjeroen goodclinicaltrialsbyremovingdefensiveinterpretationofgoodclinicalpracticeguidelines AT groeneveldgeertjan goodclinicaltrialsbyremovingdefensiveinterpretationofgoodclinicalpracticeguidelines AT burggraafjacobus goodclinicaltrialsbyremovingdefensiveinterpretationofgoodclinicalpracticeguidelines AT cohenadam goodclinicaltrialsbyremovingdefensiveinterpretationofgoodclinicalpracticeguidelines |